Clinical Trial Update: Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating the effectiveness and tolerance of an inhaled fentanyl aerosol (25 µg per dose) in Chinese patients with breakthrough canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breakthrough Cancer Pain
• Cancer Pain

Drugs mentioned

• Inhaled fentanyl aerosol (25µg/dose) (fentanyl)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Breakthrough Cancer Pain | Phase 1, Phase 2 | Status: UNKNOWN